Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

preview_player
Показать описание
In this activity, Prof. Heather Wakelee, a leading expert in the management of non-small cell lung cancer (NSCLC), discusses the use of immunotherapy in the treatment of early-stage, resectable NSCLC. She reviews pivotal clinical trials and recent data from ASCO 2024, focusing on their implication for clinical practice.

Or

This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.
  1. Touch Medical Media
Рекомендации по теме
Immunotherapy for early-stage, 0:32:52

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

Immunotherapy for Early-Stage 0:29:49

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Early-Stage Resectable NSCLC: 0:48:52

Early-Stage Resectable NSCLC: A Shifting Landscape With Targeted Therapies and Immunotherapy

Dr. Menter on 0:01:26

Dr. Menter on Neoadjuvant Immunotherapy in Early-Stage NSCLC

Immunotherapy as combination 0:03:44

Immunotherapy as combination and neoadjuvant therapies in NSCLC

Realizing the Promise 0:43:46

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC

Expert report on 0:07:00

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

Developments in neoadjuvant 0:03:53

Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients

Clinical and translational 0:04:19

Clinical and translational results from the NEOSTAR study: treating early-stage lung cancer with...

Immunotherapies in Lung 0:26:13

Immunotherapies in Lung Cancer | 2022 Evolution Conference

Advances in Immunotherapy 0:45:21

Advances in Immunotherapy & Resectable Non-Small Cell Lung Cancer

Marking New Milestones 0:59:24

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer

Marking New Milestones 0:59:37

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer

Adherence & outcomes 0:00:58

Adherence & outcomes of neoadjuvant immunotherapy in resectable NSCLC

Treatment of Early-Stage 0:05:36

Treatment of Early-Stage NSCLC

8 in 8 0:06:37

8 in 8 Series: Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC

Early intervention neoadjuvant 0:01:02

Early intervention neoadjuvant immunotherapy in lung cancer

Has Immunotherapy Brought 1:08:00

Has Immunotherapy Brought Us to an Inflection Point in the Management of Stage I-III NSCLC?

Immunotherapy for Patients 0:01:46

Immunotherapy for Patients with Resectable NSCLC & Driver Mutation-Targeted Therapies in Lung Ca...

Unleashing the Potential 0:39:06

Unleashing the Potential of Perioperative Immunotherapy in Resectable NSCLC

Neoadjuvant Nivolumab in 0:06:45

Neoadjuvant Nivolumab in NSCLC

PD-L1 expression in 0:30:02

PD-L1 expression in early NSCLC: Interpreting the data so far | Heather Wakelee & Nasser Altorki

IMpower010 supports adjuvant 0:09:24

IMpower010 supports adjuvant atezolizumab in early-stage NSCLC | Heather Wakelee

How to Integrate 0:49:11

How to Integrate Perioperative Immunotherapy Into Multimodal Treatment Plans in Resectable NSCLC

Комментарии
Автор

Hey, loved the vibe🙌!
I'm not really sure if it is the best time to ask but, I was wondering if I could help you create a better distribution by working on post-production like better storytelling through Edits, Keywords, think catchy intros and outros, or even some engaging short clips!

Would love to chat if you're interested.

Anurag-je